Business
Mainz Biomed Reports Results of 2024 Annual General Meeting
BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing
About this update from Quantum Cyber N.v.
[{"type":"text","content":"BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting (“Annual General Meeting”) on Friday, May 31, 2024 in Amsterdam, The Netherlands. Holders of 2,431,947 ordinary shares, representing approximately 10.9% of our outstanding shares on May 3, 2024, the record date for the Annual General Meeting, were present at such meeting, which constituted a quorum under Dutch law. Each of the matters presented at the Annual General Meeting received the requisite shareholder approval as set below: ProposalForAgainstAbstain 1.Adoption of the statutory annual accounts for the financial year ended 31 December 20232,400,44922,5288,970 2.Discharge from liability of the directors for their management and supervision during the financial year ended 31 December 20232,187,602198,94945,396 3.Amendment of the articles of association and authorization of CMS to have the deed of amendment of articles of association executed2,344,80132,16654,980 4.Extension of the authorization of the board to acquire ordinary shares or depositary receipts thereof2,229,837169,97232,138 5.Extension of the authorization of the board to acquire preferred shares or depositary receipts thereof2,103,796296,90131,250 6.Reappointment of Mr. G. Baechler as executive director2,368,37631,47632,095 7.Reappointment of Mr. H.J. Hekland as non-executive director2,371,38131,48129,085 8.Reappointment of Mr. G.J. Tibbitts as non-executive director2,378,15446,4437,350 9.Reappointment of Dr. H. Dreismann as non-executive director2,372,91029,93929,098 10.Assignment of Kreston Lentink Audit B.V. as Dutch auditor and authorization of the board to assign a US auditor at its discretion for the financial year ending 31 December 20242,378,05225,90727,988 No other matters were voted upon at the Annual General Meeting.In addition to announcing the results of its Annual General Meeting, Mainz also addresses a recent notification from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (\"Nasdaq \") regarding the company's compliance with the minimum bid price requirement. Nasdaq has informed Mainz that it is currently not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price of the company's ordin...